
Keywords: ALK; anaplastic lymphoma kinase; ATP; adenosine triphosphate; BCR-ABL; Breakpoint cluster region-Abelson; DMEM; Dulbecco Modified Eagle Medium; EGFR; epidermal growth factor receptor; FUCCI; Fluorescence Ubiquitination Cell Cycle Indicator; HER; human e